Background Uganda recently adopted artemether-lumefantrine (AL) as the recommended
first-line treatment for uncomplicated malaria. However, AL has several limitations, including …

Objectives To compare the efficacy and safety of artemether-lumefantrine (AL) and
dihydroartemisinin-piperaquine (DP) for treating uncomplicated falciparum malaria in …

Objectives To compare the efficacy and safety of artemisinin combination therapies for the
treatment of uncomplicated falciparum malaria in Uganda. Design Randomized single-blind …

Background Artemether–lumefantrine (AL) and artesunate–amodiaquine are first-line
treatment for uncomplicated malaria in many endemic countries, including Mali …

Background Artemisinin-based combination regimens are widely advocated for malarial
treatment, but other effective regimens might be cheaper and more readily available. Our …

Background. In treating malaria in Uganda, artemether-lumefantrine (AL) has been
associated with a lower risk of recurrent parasitemia, compared with artesunate …

Background Prompt diagnosis and effective treatment are considered the cornerstones of
malaria control and artemisinin-based combination therapy (ACT) is currently the main anti …

Background The choice of appropriate artemisinin-based combination therapy depends on
several factors (cost, efficacy, safety, reinfection rate and simplicity of administration). To …

Abstract Background In Uganda, artemether-lumefantrine (AL) is first-line therapy and
dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated …

Background Artemether–lumefantrine and artesunate–amodiaquine are used as first-line
artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate …